Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya Perera

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacy and Pharmacology|January 3, 2013
Diurnal variation in CYP1A2 enzyme activity in South Asians and EuropeansVidya Perera, Annette S Gross, Andrew J McLachlan
Biomedical Chromatography : BMC|September 21, 2010
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasmaVidya Perera, Annette S Gross, Andrew J McLachlan
Current Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlan
The Journal of Pharmacy and Pharmacology|August 11, 2011
Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metricsVidya Perera, Annette S Gross, Hongmei Xu, et al.
Age and Ageing|January 20, 2009
The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillationVidya Perera, Beata V Bajorek, Slade Matthews, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic modelMichael J Dolton, Vidya Perera, Lisa G Pont, et al.
Journal of Bacteriology|August 31, 2016
Cho Endonuclease Functions during DNA Interstrand Cross-Link Repair in Escherichia coliAnthonige Vidya Perera, James Brian Mendenhall, Charmain Tan Courcelle, et al.
Journal of Clinical Pharmacology|December 18, 2024
Drug-Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model-Based StudiesSamira Merali, Caroline Sychterz, Vidya Perera, et al.
European Journal of Pediatrics|June 27, 2015
Prediction of plasma caffeine concentrations in young adolescents following ingestion of caffeinated energy drinks: a Monte Carlo simulationJung Woo Lee, Yookyung Kim, Vidya Perera, et al.
Clinical Pharmacology in Drug Development|September 29, 2023
Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug-Drug Interaction Studies in Healthy ParticipantsVidya Perera, Daniel D Gretler, Julie D Seroogy, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacy and Pharmacology|January 3, 2013
Diurnal variation in CYP1A2 enzyme activity in South Asians and EuropeansVidya Perera, Annette S Gross, Andrew J McLachlan
Biomedical Chromatography : BMC|September 21, 2010
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasmaVidya Perera, Annette S Gross, Andrew J McLachlan
Current Drug Metabolism|May 5, 2012
Measurement of CYP1A2 activity: a focus on caffeine as a probeVidya Perera, Annette S Gross, Andrew J McLachlan
The Journal of Pharmacy and Pharmacology|August 11, 2011
Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metricsVidya Perera, Annette S Gross, Hongmei Xu, et al.
Age and Ageing|January 20, 2009
The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillationVidya Perera, Beata V Bajorek, Slade Matthews, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2013
Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic modelMichael J Dolton, Vidya Perera, Lisa G Pont, et al.
Journal of Bacteriology|August 31, 2016
Cho Endonuclease Functions during DNA Interstrand Cross-Link Repair in Escherichia coliAnthonige Vidya Perera, James Brian Mendenhall, Charmain Tan Courcelle, et al.
Journal of Clinical Pharmacology|December 18, 2024
Drug-Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model-Based StudiesSamira Merali, Caroline Sychterz, Vidya Perera, et al.
European Journal of Pediatrics|June 27, 2015
Prediction of plasma caffeine concentrations in young adolescents following ingestion of caffeinated energy drinks: a Monte Carlo simulationJung Woo Lee, Yookyung Kim, Vidya Perera, et al.
Clinical Pharmacology in Drug Development|September 29, 2023
Effects of Omeprazole and Verapamil on the Pharmacokinetics, Safety, and Tolerability of Mavacamten: Two Drug-Drug Interaction Studies in Healthy ParticipantsVidya Perera, Daniel D Gretler, Julie D Seroogy, et al.
Pageof 5